StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · ARAY·Healthcare

Accuray Incorporated Stock Analysis & AI Score

Accuray Incorporated (ARAY) has an ST Score of 33.6 (C-), driven by its Forecast (B+) and held back by its Momentum (D-). Analysts rate it Buy with a $2.00 price target (+1308.5% upside).

Market Closed
$0.14
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
34
ST Score
33.6/100C-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of

AI Daily Briefing

Analysis by AI

ARAY Stock Price History

—

ARAY Technical Indicators

FMP

Earnings Surprises

Analyst Forecast

Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…

Analyst Price Target

ESG Score

ARAY Latest Stock News

ST Score

ARAY
33.6out of 100
Grade C-

Accuray Incorporated (ARAY) has an ST Score of 33.6 (C-), driven by its Forecast (B+) and held back by its Momentum (D-). Analysts rate it Buy with a $2.00 price target (+1308.5% upside).

Strongest
ForecastB+
Weakest
MomentumD-
All factor grades
  • ForecastB+
  • ValuationB
  • ProfitabilityC+
  • GrowthD+
  • Financial StrengthD
  • MomentumD-
  • Piotroski2/9
Score methodology

Press Releases

Company Contact Details

ARAY stock: frequently asked questions

What is ARAY's ST Score?

Accuray Incorporated (ARAY) has an ST Score of 33.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is ARAY a buy, hold, or sell?

Analysts rate ARAY a Buy, with a price target of $2.00 (+1308.5% vs the current price). Our ST Score grades it C- (33.6/100). The ST Score is a data-driven signal, not a recommendation.

What are ARAY's factor grades?

Valuation B, Profitability C+, Financial Strength D, Momentum D-, Growth D+, Forecast B+.

What is ARAY's valuation grade?

Accuray Incorporated (ARAY) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is ARAY's growth grade?

Accuray Incorporated (ARAY) earns a growth grade of D+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is ARAY's profitability grade?

Accuray Incorporated (ARAY) earns a profitability grade of C+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is ARAY's financial strength grade?

Accuray Incorporated (ARAY) earns a financial strength grade of D, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for ARAY?

The average analyst price target for Accuray Incorporated (ARAY) is $2.00 from 13 analysts, which is +1308.5% versus the recent price of $0.14.

What is ARAY's Piotroski score?

Accuray Incorporated (ARAY) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.